Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients

被引：34

作者：

Ballani, Piya

Tran, Michael T.

Navar, Maria D.

Davidson, Mayer B.

机构：

[1] Charles R Drew Univ Med & Sci, Clin Ctr Res Excellence, Los Angeles, CA 90059 USA

[2] Martin Luther King Jr Drew Med Ctr, Dept Internal Med, Los Angeles, CA USA

来源：

DIABETES CARE | 2006年 / 29卷 / 11期

关键词：

D O I：

10.2337/dc06-1478

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：2504 / 2505

页数：2

共 9 条

[1] ENHANCED EFFICACY OF U-500 INSULIN IN THE TREATMENT OF INSULIN RESISTANCE CAUSED BY TARGET TISSUE INSENSITIVITY [J].

BAUMANN, G ;

DROBNY, EC .

AMERICAN JOURNAL OF MEDICINE, 1984, 76 (03) :529-532

[2] The use of U-500 in patients with extreme insulin resistance [J].

Cochran, E ;

Musso, C ;

Gorden, P .

DIABETES CARE, 2005, 28 (05) :1240-1244

[3]

HARMEL AP, 2004, DAVIDSONS DIABETES M, P133

[4] Five fold increase of insulin concentration delays the absorption of subcutaneously injected human insulin suspensions in pigs [J].

Jorgensen, KH ;

Hansen, AK ;

Buschard, K .

DIABETES RESEARCH AND CLINICAL PRACTICE, 2000, 50 (03) :161-167

[5]

Knee Treyce S, 2003, Endocr Pract, V9, P181

[6]

Lane Wendy S, 2006, Endocr Pract, V12, P251

[7] U-500 INSULIN IN THE TREATMENT OF ANTIBODY-MEDIATED INSULIN RESISTANCE [J].

NATHAN, DM ;

AXELROD, L ;

FLIER, JS ;

CARR, DB .

ANNALS OF INTERNAL MEDICINE, 1981, 94 (05) :653-656

[8]

Neal J Matthew, 2005, Endocr Pract, V11, P305

[9] Use of U-500 regular insulin in type 2 diabetes [J].

Wafa, Wafic S. ;

Khan, Mukhtar I. .

DIABETES CARE, 2006, 29 (09) :2175-2176

← 1 →